Jenifer Matthews, MD

Dr. Michlitsch joined the clinical faculty in 2010 and was selected because of her outstanding work as a Hem/Onc Fellow. While focusing in her fellowship on epigenetic silencing of transgenes, she maintained a strong commitment to clinical oncology and hematology. Recently, she became Director of the Oncology Tumor Board. Dr. Michlitsch has become the Oakland PI for phase I trials with UCSF including Co-PI for “Discovering Therapeutic Targets Using Circulating Tumor DNA in Pediatric Patients with Solid and CNS Malignancies: A Pilot Study” – joint study with UCSF, PI for the Oakland campus, and is working to open with UCSF institutional Phase 1 study of “Pazopanib in Combination with Irinotecan and Temozolomide for Children and Young Adults with Relapsed or Refractory Sarcomas”. Dr. Michlitsch is very active in the teaching program and the fellow Scholarship Oversight Committee. She is a mentor for the CHORI Minority Summer Student Program. She is responsible for demonstrating and supervising fellows and residents in hematology/oncology procedures including intrathecal therapy, bone marrow aspirations, and ommaya taps. She is an active member of our outreach program.

Selected Research and Publications:

1. Michlitsch JG. Cardiopulmonary Emergencies. In: Agrawal AK, Hastings CH, Feusner J, eds. Supportive Care in Pediatric Oncology. Berlin: Springer; 2014 (in press).
2. Michlitsch JG, Azimi M, Hoppe C, Lorey F, Walters MC, Lubin B, Vichinsky E. Newborn screening for hemoglobinopathies in California. Pediatr Blood Cancer 2008; Dec 5. [Epub ahead of print]
3. Michlitsch JG and Walters MC. Recent advances in bone marrow transplantation in hemoglobinopathies. Curr Mol Med 2008:8(7):675-89.
4. Hagar RW, Michlitsch JG, Gardner J, Vichinsky EP, Morris CR. Clinical differences between children and adults with pulmonary hypertension and sickle cell disease. Br J Haematol 2008;140(1):104-12.